New requirements represent material changes to common industry practices
A new set of requirements from the state of New Jersey has captured the attention of the pharmaceutical compliance world. The requirements became effective on Jan. 15, 2018, in a document titled “Limitations on and Obligations Associated with Prescriber Acceptance of Compensation from Pharmaceutical Manufacturers.” Two requirements from this new law, the caps on bona fide services and meals, are making headlines, and justifiably so. Both represent material changes to common industry practices and puts the onus on healthcare professionals (HCPs) to track their own aggregate compensation.
Read the full article to discover how you may be impacted by the New Jersey requirements.